Terms: = Head and neck cancer AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70 AND Treatment
26608 results:
1. Early postoperative systemic inflammatory response as predictor of anastomotic leakage after esophagectomy: a systematic review and meta-analysis.
Van Daele E; Vanommeslaeghe H; Peirsman L; Van Nieuwenhove Y; Ceelen W; Pattyn P
J Gastrointest Surg; 2024 May; 28(5):757-765. PubMed ID: 38704210
[TBL] [Abstract] [Full Text] [Related]
2. Contemporary outcomes for resected type 1-3 gastroesophageal junction adenocarcinoma: a single-center experience.
Stiles ZE; Hagerty BL; Brady M; Mukherjee S; Hochwald SN; Kukar M
J Gastrointest Surg; 2024 May; 28(5):634-639. PubMed ID: 38704200
[TBL] [Abstract] [Full Text] [Related]
3. Effects of concurrent chemoradiotherapy with or without Endostar on the regression of retropharyngeal lymph node and prognosis of patients with locally advanced nasopharyngeal carcinoma: a retrospective study.
Song JM; Mo N; Lv YQ; Huang LL; Wen YJ; Liu T; Li ZR; Wang RS; Zhang TT
J Cancer Res Clin Oncol; 2024 May; 150(5):232. PubMed ID: 38703186
[TBL] [Abstract] [Full Text] [Related]
4. A comparison of endoscopic endonasal versus open approaches for skull base chordoma: a comprehensive National cancer Database analysis.
Soffer JM; Ulloa R; Chen S; Ziltzer RS; Patel VA; Polster SP
Neurosurg Focus; 2024 May; 56(5):E5. PubMed ID: 38691856
[TBL] [Abstract] [Full Text] [Related]
5. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal cancer Patients Who Receive Curative treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
[TBL] [Abstract] [Full Text] [Related]
6. Radiotherapy for patients with esophageal cancer aged 80 years or older: A 16-year experience.
Zhai T; Huang R; Zhan Y; Xu L; Yu Y; Guo L; Chen J; Su C; Chen C
J Cancer Res Ther; 2024 Apr; 20(2):678-683. PubMed ID: 38687940
[TBL] [Abstract] [Full Text] [Related]
7. Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.
Shin DS; Basak S; Veena MS; Comin-Anduix B; Bhattacharya A; Dong TS; Ko A; Han P; Jacobs J; Moatamed NA; Avila L; Pellegrini M; Wang M; Srivatsan ES
Cancer Med; 2024 May; 13(9):e7212. PubMed ID: 38686626
[TBL] [Abstract] [Full Text] [Related]
8. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
9. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjörnsdottir S; Jonasson C; Hveem K; Svanström H; Melbye M; Ueda P
BMJ; 2024 Apr; 385():e078225. PubMed ID: 38683947
[TBL] [Abstract] [Full Text] [Related]
10. Outcomes of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone in Esophageal Squamous Cell Carcinoma Induction chemotherapy in Esophageal Squamous Cell Carcinoma.
Hosseini Toudeshki S; Garousi M; Arefpour AM; Fadavi P; Basi A; Foroughi A; Javadinia SA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1183-1188. PubMed ID: 38679976
[TBL] [Abstract] [Full Text] [Related]
11. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract] [Full Text] [Related]
12. Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
[TBL] [Abstract] [Full Text] [Related]
13. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
14. A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations.
Rodon J; Rodriguez E; Maitland ML; Tsai FY; Socinski MA; Berlin JD; Thomas JS; Al Baghdadi T; Wang IM; Guo C; Golmakani M; Clark LN; Gazdoiu M; Li M; Tolcher AW
ESMO Open; 2024 Apr; 9(4):102961. PubMed ID: 38640748
[TBL] [Abstract] [Full Text] [Related]
15. The role of ferroptosis in radiotherapy and combination therapy for head and neck squamous cell carcinoma (Review).
Feng Y; Li X; Yang B; Li M; Du Y; Wang J; Liu S; Gong L; Li L; Gao L
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38639185
[TBL] [Abstract] [Full Text] [Related]
16. Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial).
Goto H; Oshikiri T; Kato T; Nagatani Y; Funakoshi Y; Koterazawa Y; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Minami H; Kakeji Y
PLoS One; 2024; 19(4):e0299742. PubMed ID: 38635652
[TBL] [Abstract] [Full Text] [Related]
17. Chylous leakage after esophagectomy for esophageal cancer: a systematic review.
Zheng X; Yang X; Lei S
J Cardiothorac Surg; 2024 Apr; 19(1):240. PubMed ID: 38632619
[TBL] [Abstract] [Full Text] [Related]
18. Can predictive factors determine the time to treatment initiation for oral and oropharyngeal cancer? A classification and regression tree analysis.
Montagnoli DRABS; Leite VF; Godoy YS; Lafetá VM; Junior EAP; Chaurasia A; Aguiar MCF; Abreu MHNG; Martins RC
PLoS One; 2024; 19(4):e0302370. PubMed ID: 38630775
[TBL] [Abstract] [Full Text] [Related]
19. Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma.
Sasaki A; Takeda D; Kawai H; Tadokoro Y; Murakami A; Yatagai N; Arimoto S; Nagatsuka H; Akashi M; Hasegawa T
PLoS One; 2024; 19(4):e0302194. PubMed ID: 38630690
[TBL] [Abstract] [Full Text] [Related]
20. X-ray-guided self-expandable metal stent (SEMS) implantation in oesophageal malignancy as an alternative treatment.
Ziaja D; Sznapka M; Stasiów B; Ziaja K; Chudek J
Pol Przegl Chir; 2024 Apr; 96(2):21-25. PubMed ID: 38629277
[TBL] [Abstract] [Full Text] [Related]
[Next]
